Elevance Health, Inc. 8-K

What Happened
Elevance Health, Inc. (ELV) filed an 8-K on January 28, 2026 (Item 2.02), furnishing a press release that announced the company's fourth quarter and full-year 2025 financial results. The press release covering the quarter ended December 31, 2025, is provided as Exhibit 99.1 to the filing and is incorporated by reference.

Key Details

• Date of press release: January 28, 2026 (furnished as Exhibit 99.1).
• Reporting period: quarter ended December 31, 2025 (Q4 2025) and full-year 2025 results.
• Filing items: Item 2.02 (Results of Operations and Financial Condition) and Exhibit 104 (Inline XBRL interactive data file) were included.
• The release contains forward-looking statements with standard risk and cautionary language about factors that may cause actual results to differ.

Why It Matters
This 8-K signals that Elevance has publicly released its most recent earnings and operating results—information investors use to assess revenue, profitability, margins, and trends in membership or medical cost. Retail investors should read the furnished press release (Exhibit 99.1) and watch for the company’s accompanying earnings presentation, quarterly or annual reports (10-Q/10-K), and management commentary for detailed figures, drivers of performance, and any updated outlook. The filing’s forward-looking statement language also highlights risks investors should consider when evaluating any guidance or projections.